Verita Pharma

Verita Pharma was a pharmaceutical development company and a subsidiary of the Verita Healthcare Group, specializing in integrative medicine and personalized healthcare solutions. The company focused on the development of proprietary protocols and products for oncology, chronic disease management, and regenerative medicine, often utilizing repurposed drugs and advanced delivery systems. Verita Pharma's portfolio included metabolic-based therapies and specialized nutritional formulations designed to enhance conventional treatment outcomes. Headquartered in Singapore, the company supported an international network of clinics with its research and product development capabilities. However, following financial difficulties, its parent company, Verita Healthcare Group, entered liquidation in late 2022, leading to the cessation of Verita Pharma's primary operations.